Bulletin
Investor Alert

Allakos Inc.

NAS: ALLK

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 21, 2022, 7:43 p.m.

/zigman2/quotes/203639566/composite

$

6.89

Change

+0.04 +0.58%

Volume

Volume 292,021

Quotes are delayed by 20 min

/zigman2/quotes/203639566/composite

Previous close

$ 7.18

$ 6.85

Change

-0.33 -4.60%

Day low

Day high

$6.81

$7.42

Open

52 week low

52 week high

$6.81

$157.98

Open

Insider Actions for Allakos Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/02/2021 Robert Alexander
Chief Executive Officer; Director
20,241   Derivative/Non-derivative trans. at $78.69 per share. 1,592,764
12/02/2021 Adam L. Tomasi
President and COO
13,067   Derivative/Non-derivative trans. at $78.69 per share. 1,028,242
12/01/2021 Robert Alexander
Chief Executive Officer; Director
51,681   Award at $0 per share. 0
12/01/2021 Adam L. Tomasi
President and COO
33,362   Award at $0 per share. 0
12/01/2021 Mark A. Asbury
CLO
26,003   Award at $0 per share. 0
12/01/2021 Harlan Baird Radford
Chief Financial Officer
24,255   Award at $0 per share. 0
09/28/2021 Steven P. James
Director
4,000   Disposition at $108.12 per share. 432,480
09/28/2021 Steven P. James
Director
4,000   Derivative/Non-derivative trans. at $0.52 per share. 2,080
09/02/2021 Robert Alexander
Chief Executive Officer; Director
3,985   Derivative/Non-derivative trans. at $91.66 per share. 365,265
09/02/2021 Adam L. Tomasi
President and COO
2,346   Derivative/Non-derivative trans. at $91.66 per share. 215,034
09/02/2021 Mark A. Asbury
CLO
698   Derivative/Non-derivative trans. at $91.66 per share. 63,978
08/31/2021 Adam L. Tomasi
President and COO
64,148   Derivative/Non-derivative trans. at $4.31 per share. 276,477
06/15/2021 Adam L. Tomasi
President and COO
20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
06/15/2021 Adam L. Tomasi
President and COO
20,000   Disposition at $91.03 per share. 1,820,600
06/14/2021 Adam L. Tomasi
President and COO
20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
06/14/2021 Adam L. Tomasi
President and COO
20,000   Disposition at $91.62 per share. 1,832,400
06/07/2021 Adam L. Tomasi
President and COO
2,487   Disposition at $92.03 per share. 228,878
06/04/2021 Robert Alexander
Chief Executive Officer; Director
5,482   Disposition at $89.64 per share. 491,406
06/04/2021 Robert Alexander
Chief Executive Officer; Director
3,597   Disposition at $89.62 per share. 322,363
06/04/2021 Robert Alexander
Chief Executive Officer; Director
14,516   Disposition at $89.64 per share. 1,301,214
06/04/2021 Adam L. Tomasi
President and COO
642   Disposition at $90.26 per share. 57,946
06/04/2021 Henrik Sandvad Rasmussen
Chief Medical Officer
2,435   Disposition at $89.6 per share. 218,176
06/04/2021 Robert Alexander
Chief Executive Officer; Director
14,516   Derivative/Non-derivative trans. at $0.69 per share. 10,016
06/03/2021 Robert Alexander
Chief Executive Officer; Director
5,484   Disposition at $92.09 per share. 505,021
06/03/2021 Robert Alexander
Chief Executive Officer; Director
14,517   Disposition at $92.14 per share. 1,337,596
06/03/2021 Robert Alexander
Chief Executive Officer; Director
4,003   Derivative/Non-derivative trans. at $92.2 per share. 369,076
06/03/2021 Adam L. Tomasi
President and COO
1,777   Derivative/Non-derivative trans. at $92.2 per share. 163,839
06/03/2021 Henrik Sandvad Rasmussen
Chief Medical Officer
834   Derivative/Non-derivative trans. at $92.2 per share. 76,894
06/03/2021 Mark A. Asbury
CLO
734   Derivative/Non-derivative trans. at $92.2 per share. 67,674
06/03/2021 Robert Alexander
Chief Executive Officer; Director
14,517   Derivative/Non-derivative trans. at $0.69 per share. 10,016

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
2 Sales
135,301
33,308
Last 6 months
6 Purchases
6 Sales
203,449
44,337
Last 12 months
34 Purchases
92 Sales
699,366
768,276

Officers and Executives

Dr. Robert Alexander
Chief Executive Officer & Director
Dr. Adam L. Tomasi
President & Chief Operating Officer
Mr. Harlan Baird Radford
Chief Financial Officer
Dr. Ruby Casareno
Vice President-Technical Operations
Dr. Craig Paterson
Chief Medical Officer
Mr. Roland K. Winger
Senior Vice President
Dr. Sally D. Bolmer
Vice President-Regulatory Affairs & Development
Mr. Mark A. Asbury
Chief Legal Officer & General Counsel
Mr. Dan S. Janney
Chairman
Dr. John P. McKearn
Independent Director
Mr. Steven P. James
Independent Director
Mr. Paul E. Walker
Independent Director
Mr. Robert E. Andreatta
Independent Director
Link to MarketWatch's Slice.